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Abstract
Brain fatty acid binding protein (Fabp7), which is important in early nervous system development, is expressed in astrocytes
and neuronal cell precursors in mature brain. We report here that levels of Fabp7 mRNA in adult murine brain change over a
24 hour period. Unlike Fabp5, a fatty acid binding protein that is expressed widely in various cell types within brain, RNA
analysis revealed that Fabp7 mRNA levels were elevated during the light period and lower during dark in brain regions
involved in sleep and activity mechanisms. This pattern of Fabp7 mRNA expression was confirmed using in situ hybridization
and found to occur throughout the entire brain. Changes in the intracellular distribution of Fabp7 mRNA were also evident
over a 24 hour period. Diurnal changes in Fabp7, however, were not found in postnatal day 6 brain, when astrocytes are not
yet mature. In contrast, granule cell precursors of the subgranular zone of adult hippocampus did undergo diurnal changes
in Fabp7 expression. These changes paralleled oscillations in Fabp7 mRNA throughout the brain suggesting that cell-
coordinated signals likely control brain-wide Fabp7 mRNA expression. Immunoblots revealed that Fabp7 protein levels also
underwent diurnal changes in abundance, with peak levels occurring in the dark period. Of clock or clock-regulated genes,
the synchronized, global cycling pattern of Fabp7 expression is unique and implicates glial cells in the response or
modulation of activity and/or circadian rhythms.
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Introduction
Brain fatty acid binding protein (also known as brain lipid
binding protein or Fabp7) is a member of a large family of fatty
acid binding proteins (Fabps) of relatively small molecular weight
(,15 kD) that are expressed in a diverse set of vertebrate and
invertebrate tissues [1]. Fabps, which facilitate the solubility of
hydrophobic long chain fatty acids and function primarily in fatty
acid uptake and transport [2], have been widely implicated in cell
growth and differentiation [3–7]. In the central nervous system
(CNS), three Fabp proteins with different cell-type distributions
have been identified: Heart-type Fabp (Fabp3), epidermal-type
Fabp (Fabp5), and brain-type Fabp, Fabp7 [8,9]. Fabps within
brain are thought to govern the uptake and delivery of fatty acids
like docosahexanoic acid (DHA) and arachadonic acid and to play
important roles in cell differentiation [3,10,11].
The initial identification of Fabp7 established its presence
within radial glia in embryonic brain and in neuronal cell
progenitors in mature brain [3,12,13]. In fact, most neuronal cell
populations are thought to be derived from Fabp7-expressing
progenitors [14]. The regulation of Fabp7 mRNA expression has
been shown to be downstream of Notch signaling [15], and
dependent on Pax6 [14,16] and POU/Pbx transcription factors
[17]. Fabp7 mRNA levels were found to peak at birth and to
undergo a dramatic reduction during early postnatal development,
but to persist in radial glia-like neuronal progenitors and specific
mature astrocyte populations [13]. Although the role of Fabp7 in
fatty acid delivery during development is not clear, its involvement
in cell growth and differentiation has been implicated based on its
influence on cell morphology [3]. Further, an induction of Fabp7
increases the motility of glioma cells [18].
Recently it has been shown that the targeted deletion of Fabp7
results in an enhancement of fear memory and anxiety in
adulthood [9]. Interestingly, the ability of the fatty acid, DHA to
modulate NMDA receptor activation in hippocampal neurons is
eliminated in these Fabp7-mutant mice. Whether these effects are
due to cell-intrinsic changes that occur in the absence of Fabp7
during neuronal cell precursor maturation or are a result of an
absence of Fabp7 in mature astrocytes is not known.
Changes in the expression of molecules involved in the
regulation of the circadian cycle have been shown to have strong
functional and behavioral consequences. For example, mutations
in various clock genes have been shown to alter feeding behavior
[19–22], long-term memory formation [23,24] and to exert strong
effects on drug conditioning behavior in both flies and mice [25–
27]. We have previously shown that Fabp7 also undergoes diurnal
changes in expression in hypothalamus [28]. Given the potential
role of Fabp7 in neurogenesis and anxiety mechanisms, and the
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expression of Fabp7 throughout the brain and found that it
underwent global and coordinated diurnal regulation in astrocytes.
Further, this synchronized cycling pattern in astrocytes was also
observed in granule cell progenitors of the hippocampus.
Results
Fabp7 mRNA is diurnally expressed in brain regions
involved in the regulation of arousal
Fabp7, a protein present in astrocytes and related cell types
[3,12,13], undergoes diurnal changes in mRNA abundance in
regions of murine hypothalamus that are involved in sleep/wake
regulation and circadian rhythmicity [28]. Fabp7 mRNA
expression also cycles over a 48 hour period within the
suprachiasmatic nucleus, where oscillations persisted in dark
(free-running) conditions [29,30]. To determine whether Fabp7
mRNA is diurnally expressed in other brain regions involved in
activity, we examined the cycling of Fabp7 mRNA in the
tuberomammilary nucleus (TMN), which contains histaminergic
neurons thought to play a primary role in brain arousal [31–33],
the pons, a brain area that has a broad role in activity states and
the locus coeruleus (LC), which contains norepinephrine-releasing
cells important in regulating sleep and activity [34]. Within these
three regions, Fabp7 mRNA levels at Zeitgeber time (ZT) 6 (the
middle of the light period) were three to five-fold higher than
ZT18 (the middle of the dark period; Fig. 1A). Detailed time point
analysis of TMN, pons and LC further revealed a gradual decrease
in Fabp7 mRNA during the light period followed by an increase in
levels at the end of dark (Fig. 1B). The diurnal pattern of Fabp7
mRNA expression was strikingly similar in all three brain regions
and was identical to the diurnal change in Fabp7 mRNA levels
evident in hypothalamus [28].
The diurnal pattern of Fabp7 mRNA expression was compared
to epidermal-type fatty acid binding protein, Fabp5, which is
expressed in a number of cell types in brain including astrocytes
[10,11]. Unlike Fabp7, Fabp5 mRNA was not found to cycle in
the TMN, pons or LC (Fig. 1B). Collapsed data from figure 1B is
depicted as relative signal intensity in figure 1C to illustrate
differences in diurnal expression between Fabp7 and 5. Significant
differences were evident in Fabp7, but not Fabp5, mRNA levels
Figure 1. Fabp7 mRNA is diurnally regulated in brain regions involved in sleep and activity. A) RNA collected from tuberomammillary
nucleus (TMN), pons and locus coeruleus (LC) subjected to Northern blotting revealed elevated levels of Fabp7 mRNA at Zeitgeber time (ZT) 6
compared to ZT18 (bottom panel). Glyeraldehyde-3-phosphate dehydrogenase (Gapdh) was used as a loading control. Graphic representation of
Fabp7 expression normalized against Gapdh indicated 3 to 5 fold changes in mRNA levels (top panel); **p,0.01, *p,0.05, t=0.06 (t-test). Each time
point represents 12 individual animals pooled. N=2–3 groups. B) Northern blot analysis of RNA collected every 4 hours showed diurnal changes in
Fabp7 mRNA but not Fabp5. C) Collapsed data from B normalized with Gapdh indicated significant diurnal changes in Fabp7 mRNA across a 24-hour
period but no changes in Fabp5 expression. One-way ANOVA, ***p,0.001, **p,0.01 (post-hoc Bonferroni). Each value represents the regional
average +/2 S.E.M. Each time point represents 3 individual animals pooled.
doi:10.1371/journal.pone.0001631.g001
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type fatty acid binding protein (Fabp3), which is exclusive to
neurons, was also not found to cycle (data not shown). The pattern
of Fabp7 expression in diurnal samples of RNA from pons
subjected to quantitative RT-PCR (qRT-PCR) closely matched
Northern blotting data (Fig. S1).
To determine whether pre-processed heteronuclear (hn) Fabp7
RNA underwent similar changes in abundance, we used qRT-
PCR to examine the relative concentrations of Fabp7 intron 1 in
TMN, pons and LC across a diurnal profile (Fig. S1). These results
indicated that higher intron 1 hnRNA levels were generally
present around the dark-to-light period transition. In situ
hybridization with probe to intron 1 confirmed qRT-PCR results
(data not shown). These results suggest that the increase in Fabp7
mRNA that occurs near the end of the dark period is due to
enhanced transcriptional activity.
Diurnal changes in Fabp7 mRNA occur throughout the
brain
In situ hybridization was used to examine the diurnal profile of
Fabp7 mRNA expression in more detail. Highest signal intensities
were evident during the light period in agreement with results
using Northern blotting and qRT-PCR RNA analyses (Fig. 2A).
At all time points, signal within coronal sections at the level of
dorsal hippocampus showed highest intensities in stria medullaris/
hebenula (Hb), amygdala (A) and hypothalamus (Hy). Sagittal
Figure 2. Fabp7 mRNA changes globally during the diurnal period. A) Coronal (top series) and sagittal (bottom series) sections from four
diurnal time points subjected to in situ hybridization using
35S-labeled Fabp7 antisense riboprobe. Note more intense expression levels during lights-
on. B) Graphic representation of relative Fabp7 mRNA expression at four time points. A statistically significant diurnal variation in expression was
observed; Two-way ANOVA (p,0.001). ***p,0.001, **p,0.01 versus ZT18 (post-hoc Bonferroni). Each value represents the average +/2 S.E.M. N=2–
5 per time point. A, Amygdala; Cb, cerebellum; CC, cerebral cortex; Hb, medullaris/hebenula; Hy, hypothalamus; OB, olfactory bulb; T, thalamus
doi:10.1371/journal.pone.0001631.g002
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indicated high levels in cerebellum (Cb) and olfactory bulb (OB).
Densitometric measurements from a number of brain regions that
included thalamus (T), Hb, cerebral cortex (CC) and Cb revealed
the diurnal regulation of Fabp7 expression to include a broader
pattern that extended beyond regions known to specifically
influence sleep/wake or circadian rhythmicity.
Given that the recently described Chordc1 mRNA has been
shown to cycle globally in brain during early postnatal development
[35], and that Fabp7 mRNA is abundant in rat [12] and mouse
brain (Fig. S2A), we examined Fabp7 mRNAexpression at postnatal
day 6, when many astrocytes have completed migration and are
beginning tomature[36]. Unlikeadult brain, Fabp7 mRNAwasnot
found to cycle in P6 brain (Fig. S2B).
Fabp7 protein levels are elevated during the dark period
ImmunoblottingwasusedtodeterminewhetherchangesinFabp7
mRNA levels resulted in changes in Fabp7 protein. Since Northern
blotting and in situ hybridization indicated that Fabp7 mRNA levels
underwent the same pattern of diurnal regulation regardless of brain
region, we examined Fabp7 protein levels in whole brain extracts
collected at four diurnal time points. Like Fabp7 mRNA, Fabp7
protein levels were found to differ depending on time of day (Fig. 3).
The highest amounts of protein were evident at ZT18 and were
statistically different than the lowest amounts found at ZT0 (t-test,
p,0.05). HigherFabp7 protein levelsduring the darkperiod were in
contrast with mRNA levels, which were highest during the day
suggesting that Fabp7 protein accumulation lagged peak Fabp7
mRNA levels by about 12 hours.
Fabp7 mRNA is diurnally regulated in amygdala and may
undergo changes in intracellular distribution during the
light-dark cycle
Fabp7 has recently been implicated in fear memory and anxiety
[9] and we therefore examined the region-specific distribution of
Fabp7 mRNA in amygdala and hippocampus. In amygdala,
Fabp7 mRNA cycled identically to other brain regions with
highest mRNA levels present in the light period (Fig. 4). This
distinctive pattern of expression was evident in both basolateral
(BLA) and medial (MA) nuclei (Fig. 4A) where significant changes
in mRNA levels oscillated throughout the diurnal cycle (Fig. 4B).
More detailed analysis using emulsion autoradiography confirmed
elevated levels of Fabp7 mRNA during lights-on (compare
Fig. 4C1 and C2). Higher magnification analysis of BLA revealed
that silver grain distribution corresponding to Fabp7 mRNA was
more disperse at ZT6 compared to ZT18 (compare 4C3 and C4).
Note the more dense accumulation of silver grains around cell
somata at ZT18 (arrow in 4C4) compared to ZT6 (arrow in 4C3).
A more dispersed distribution of sliver grains was common
throughout the brain toward the end of the light period (data not
shown) and these observations suggest that the diurnal change in
Fabp7 mRNA abundance may coincide with changes in mRNA
targeting. The pattern of expression of Fabp7 mRNA was
consistent with an astrocytic labeling pattern as has been shown
previously [9] and cells that stained with DIG-labeled Fabp7
riboprobe were also found to co-label with radiolabeled probe to
the astrocyte mRNA, Glial fibrillary acidic protein (4C5).
Immunostained images of Fabp7-expressing astrocytes in BLA
are shown for reference (Fig. 4C6).
Diurnal changes in Fabp7 mRNA levels in hippocampus
are also present in granule cell precursors
Fabp7 mRNA was also diurnally regulated in hippocampus
with higher relative levels of expression present in the hippocam-
pal fissure (HF) and dentate gyrus (DG; Fig. 5A). Expression of
Fabp7 was pronounced in the subgranular zone (SGZ) of DG and
was higher during lights-on (arrowheads in Fig. 5A). These
changes were found to be significant in the hippocampus as well as
within the granule cell precursor layer (Fig. 5B).
Higher resolution autoradiograpy confirmed intense expression
of Fabp7 mRNA in cells within the SGZ that was absent from the
granule cell layer (GCL; Fig. 5C). Silver grain accumulation over
cells within this region (arrowheads in Fig. 5C3 and C4) indicated
higher Fabp7 expression at ZT6. Granule cell precursors within
this layer, which are known to express Fabp7 [37], give rise to
granule neurons throughout the life of the animal [38]. These cells
Figure 3. Fabp7 protein levels are elevated during the dark period. Graphic representation of Western blots from whole brain indicating an
increase in Fabp7 protein levels with increasing Zeitgeber time. There is a significant increase in Fabp7 protein at ZT18 compared to ZT0,*p,0.05 (t-
test). Each value represents the average +/2 S.E.M. N=3–4 per time point. Values are normalized to an average of Gapdh and b-actin. Inset:
Representative immunoblot of whole brain homogenates from tissue isolated at four diurnal time points. A single, predicted 15 kilodalton band was
evident in blots incubated with anti-Fabp7 antibody. Blots were subsequently incubated with anti-b-actin and anti-glyceraldehyde-3-phosphate
dehydrogenase (Gapdh).
doi:10.1371/journal.pone.0001631.g003
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PLoS ONE | www.plosone.org 4 February 2008 | Volume 3 | Issue 2 | e1631Figure 4. The amount and distribution of Fabp7 mRNA in amygdala changes during the diurnal cycle. A) In situ hybridization of coronal
tissue sections probed for Fabp7 mRNA at four diurnal time points. Top panels, phosphorimages of amygdala, bottom panels, dark field images of a
different set of hybridized sections subjected to emulsion autoradiography. Higher levels of Fabp7 were evident during lights-on. B) Graphic
representation of elevated Fabp7 mRNA levels during lights-on in basolateral and medial amygdala. Two-way ANOVA (p=0.002). ***p,0.001,
**p,0.01 vs. ZT18 (post-hoc t-test). Each value represents the average +/2 S.E.M. N=2–4 per time point. C) Sections processed for in situ
hybridization for Fabp7 subjected to emulsion autoradiography. Dark field microscopy revealed a more dispersed labeling pattern at ZT 6 (C1)
compared to ZT18 (C2). Higher magnification micrographs of Nissl counterstained sections indicated labeling over cells whose staining pattern was
consistent with an astrocyte morphology and whose labeling pattern was more disperse at ZT6 (C3) compared to ZT18 (C4). Note that silver grain
accumulation around cell nuclei was similar at the two time points (arrows in C3 and C4). Astrocytes stained with DIG-labeled riboprobe for Fabp7
(unstained astrocytic nuclei (n) are indicated) were also co-labeled for mRNA for the astrocyte protein, GFAP (silver grain accumulations). Unstained
neuronal nuclei (N) are shown for reference. A representative tissue section subjected to immunohistochemistry with anti-Fabp7 antibodies is shown
in C6. Note astrocytic processes emanating from stained cell somata. Bar in A=400 mm; in C1,C2=100 mm; in C3,C4=20 mm; in C5=10 mm,
C6=30 mm BLA, basolateral amygdala; MA, medial amygdala
doi:10.1371/journal.pone.0001631.g004
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precursor in Fig. 5C5) and mRNA for the intermediate filament
protein, Nestin as previously described [37]. Precursor cells within
the SGZ were also strongly Fabp7 immunoreactive (Fig. 5C6).
Since Fabp7 is confined to radial glia-like type-1 and proliferative
type-2 cells within the SGZ [38], our results indicate that Fabp7
mRNA levels oscillate within these cells. Further, we identified
lower levels of Fabp7 expression within the granule cell layer or
directly below the SGZ in agreement with previous observations
[37] suggesting that the presence of Fabp7 in astrocytes within the
granule cell region did not contribute significantly to our analysis
of SGZ. Interestingly, we found that cells of the SGZ underwent
Figure 5. Fabp7 mRNA expression is diurnally regulated in hippocampus and subgranular zone of dentate gyrus. A) In situ
hybridization of coronal tissue sections probed for Fabp7 mRNA at four diurnal time points. Top panels, phosphorimages of hippocampus, bottom
panels, dark field images of a different set of hybridized sections subjected to emulsion autoradiography. Higher levels of Fabp7 were evident during
lights-on. Arrowheads in bottom panels indicate subgranular zone of dentate gyrus (DG). B) Graphic representation of in situ hybridization data
indicating elevated levels of Fabp7 mRNA during lights-on in hippocampus (top panel) and subgranular zone (bottom panel). One-way ANOVA
(p,0.001). ***p,0.001, **p,0.01 vs. ZT18 (post-hoc Bonferroni). Each value represents the average +/2 S.E.M. N=2–4 per time point. C) Sections
subjected to in situ hybridization for Fabp7 and emulsion autoradiography. Light- (C1, C2) and dark field (C3, C4) micrographs of sections from ZT6
and ZT18, respectively. Arrowheads indicate Fabp7 positive precursor cells in subgranular zone. Sections co-stained for Fabp7 mRNA (dark stain) and
nestin mRNA (dark silver grains) identified co-labeled precursors in the subgranular zone (C5). Sections subjected to immunohistochemistry for Fabp7
(C6) revealed radial fibers emanating from stained cell bodies (arrows) as previously described. Bar in upper, lightfield micrographs in A=500 mm; in
lower, darkfield micrographs in A=200 mm; in C1,C2=30 mm; in C3,C4=30 mm; in C5=5 mm; C6=25 mm. DG, dentate gyrus; GCL, granule cell layer;
H, hebenula; HF, hippocampal fissure; T, thalamus
doi:10.1371/journal.pone.0001631.g005
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regulation of Fabp7 expression in the hippocampus proper as well
as throughout the brain (lower panel in 5B). These results suggest
that Fabp7 mRNA undergoes synchronized diurnal changes in
expression in multiple cell-types in the brain.
Discussion
This report describes the diurnal regulation of brain fatty acid
binding protein (Fabp7) within astrocytes and subgranular zone
precursors of the adult murine brain. Synchronized cycling of
Fabp7 mRNA occurred throughout the brain with peak levels
present at the beginning of the light period and lowest levels near
lights-off. Fabp7 protein was also found to change over a 24 hour
period such that an accumulation in protein occurred towards the
middle of the dark period when Fabp7 mRNA levels were
declining. Interestingly, we observed no changes in Fabp7 mRNA
in young postnatal brain but found Fabp7 to cycle in precursor
cells of the adult hippocampus. These data suggest that Fabp7 is a
novel cycling gene and that its regulation is driven by mechanisms
that confer brain-wide, coordinated oscillations in expression.
Given that Fabp7 expression is downstream of Notch signaling
[15], Notch-mediated regulation of Fabp7 is a putative mechanism
for the oscillation in Fabp7 mRNA that we observe. In fact, a
binding site for the Notch effector CBF1 is essential for the
transcriptional regulation of Fabp7 in radial glial cells and CBF1
elements within 400 base pairs of the Fabp7 transcription start site
are necessary and sufficient for transgene activity in embryonic
and postnatal day (P) 6 brain [15]. Further, Notch signaling is
thought to synchronize the segmentation clock for somitogenesis
where it operates in somite precursor cells of the mesoderm that
oscillate through phases of the cell cycle [39]. It is not known
whether Notch signaling has a similar role later in development.
Also, we did not observe changes in Fabp7 mRNA expression
across the light-dark cycle in early postnatal brain (P6) when Notch
signaling is known to influence Fabp7 expression [15]. Since
astrocyte migration and maturation is not complete at this time in
development [36] and because Fabp7 levels are greatly elevated at
this age compared to adult [12], it may be that an inability to
observe time-of-day changes in Fabp7 mRNA levels is a result of a
ceiling affect. Conversely, it may be that the diurnal cycling of
Fabp7 mRNA is restricted to mature brain. In addition, other
transcriptional regulators, such as Pax6 and POU/Pbx have also
been found to influence the developmental profile of Fabp7
expression [16,17], suggesting alternative regulatory mechanisms
for Fabp7 transcription.
Whether Fapb7 expression is tied to known clock mechanisms or
is a component of a novel clock pathway is not known.
Bioinformatic analyses of the Fabp7 gene suggest an influence of
known clock mechanisms given the presence within the proximal
Fabp7 promoter of cis-elements such as peroxisome proliferater
activated receptor (PPRE) and E-box elements. These cis-elements
play important roles in known clock-related transcriptional
regulation [40]. Functional PPREs are present in circadian genes
such as BMAL and Rev-erb-alpha [41,42] and the PPRE-
transactivator, peroxisome proliferater activated receptor-alpha
(PPARa), is itself regulated by the circadian modulator, CLOCK
[43]. In addition, it has been shown that CLOCK:BMAL1
transactivates PPAR target genes via the PPRE [44]. Since
CLOCK is known to control the transcription of PPARs, and
PPREs are present within the Fabp7 promoter, it may be that the
diurnal oscillation in Fabp7 observed in this study is driven by a
CLOCK, PPAR-mediated pathway. Further, since other fatty acid
binding proteins have been shown to translocate to the nucleus and
directly influence PPAR-mediated transcription [45–47], and we
observe peak Fabp7 protein levels that proceed Fabp7 transcript
levels, it is intriguing to speculate that Fabp7 protein influences its
own transcription via PPAR. The importance of E-box elements in
the diurnal regulation of Fabp7, however, is uncertain since per2,
but not Fabp7, has been found to cycle in astrocyte culture [48];
Gerstner and Landry, unpublished observations). Further, unlike
Fabp7, circadian genes like CLOCK, per1, per2 and d-albumin
binding protein cycle in different temporal phases in different brain
regions [49,50]. It is likely that the regulation of Fabp7 expression
results from a combination of PPAR and E-box elements as well as
other transcriptional mechanisms. Further study will be required to
determine the elements that influence Fabp7 expression in mature
brain.
Peak Fabp7 mRNA levels preceded peak protein levels by about
12 hours and a gradual decline in mRNA occurred as protein
levels increased. These changes are similar to known circadian and
diurnally regulated genes, although the delay that we see here is
somewhat longer [51–53]. It may be that mechanisms that
influence Fabp7 mRNA levels during lights-on are in place to
increase the amount of Fabp7 protein during the active (dark)
period, perhaps in response to enhanced fatty acid demand at this
time. Since high levels in Fabp7 protein in brain during the dark
parallel diurnal changes in fatty acid binding proteins in liver and
heart, which are also elevated during the active period [54], a
mechanism for modulating the delivery or utilization of fatty acids
during activity may be a common theme in a number of organ
systems. Further, the diurnal rhythmicity of fatty acid binding
protein expression in heart and liver are influenced by levels of
serum cholesterol [54] implicating fatty acid utilization as a
modulating factor in fatty acid binding protein expression.
Diurnal cycling in processes that use fatty acids as functional
components may be a common feature of homeostatic mechanisms.
For example, fatty acid amide hydrolase (FAAH) activity has been
shown to cycle throughout the day [55], and to modulate sleep
[56,57]. Similarly, the fatty-acid metabolites anandamide and 2-
arachidonylgycerol have been shown to vary globally across the
light-dark cycle [55] and endocannabinoids such as these have been
found to participate in the regulation of complex behaviors such as
feeding, sleep/wakecycles,and responsetostress[58–60]. How fatty
acids required for these processes are delivered and distributed
within cells of the nervous system is not well understood [61] and the
cyclingofFabp7isthe firstreportofanoscillatingproteininvolved in
the movement of fatty acids. Diurnal changes in the transport and
delivery of fatty acids may therefore be a critical component of lipid-
dependant, homeostatic mechanisms.
The brain-wide diurnal regulation of Fabp7 mRNA suggests
that either a cell-autonomous mechanism governs its regulation, or
that diurnal levels are controlled by a global coordinated signaling
system. The diurnal regulation of Fabp7 within granule cell
precursors of the hippocampus suggests cell-autonomous mecha-
nisms since these cells are not astrocytes and are only transiently
Fabp7 positive [37]. However, since granule-cell precursors are
continually born within the subgranular zone [38] where we
observed synchronized diurnal expression of Fabp7, we would
predict that Fabp7 cycles similarly in precursor cells of different
birth dates, indicating a coordinated (non-cell autonomous) system
of regulation. Since astrocytes are known to contact subgranular
progenitors [62], it is likely that radial glial-like precursor cells are
capable of receiving signals from astrocytes. Further, populations
of astrocytes have been shown to undergo coordinated activity.
For example, astrocytic purinergic signaling has been shown to
synchronize pulses of calcium [63,64] and to modulate hetero-
synaptic depression through inhibition of presynaptic terminals
Diurnal Regulation of Fabp7
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derived prostaglandins, is known to modulate behavioral state,
long-term potentiation and long-term depression [66–68]. Astro-
cyte derived calcium signals have also been shown to correlate
with neuronal activity [69], and to couple this activity to cerebral
microcirculation [70]. That populations of astrocytes are capable
of coordinated activity, therefore, further supports the notion that
a broad astrocyte-mediated signaling system occurs in brain.
Although, the modulation of the cycling of Fabp7 that we observe
maybe extrinsic to the brain, i.e., driven by fluctuating serum lipid
concentrations that influence astrocyte metabolism, it seems more
likely that Fabp7 expression is driven by a yet undefined intrinsic
brain signaling system that involves astrocyte communication.
This is the first report to describe a diurnally regulated gene,
Fabp7 that cycles globally in astrocytes and related cell-types in the
mammalian central nervous system. The global cycling pattern of
Fabp7 implicates a coordinated mechanism of regulation that
extends to radial glial-like cells of the hippocampal subgranular zone
and is consistent with growing evidence that astrocytes coordinate
homeostatic mechanisms in brain. Although the mechanism for this
regulation is uncertain, other globally regulated genes, including
circadian andclock-controlledtranscripts,cycle indifferent phasesin
brain regions outside of the suprachiasmatic circadian pacemaker
making the cycling of Fabp7 unique. Given the influencethat known
circadian genes and lipid metabolites exert on complex behavior,
and the role that astrocytes play in homeostasis and plasticity, the
global cycling of Fabp7 may be intimately related to the
maintenance of these processes.
Materials and Methods
Subjects and Handling
Mice (C57BL/6) were either purchased directly from Harlan
Sprague-Dawley (adult) or taken at specific ages from a breeding
colony. A total number of 111 animals were used in this study.
Animals were entrained to a 12 hour light, 12 hour dark schedule
for at least 5 weeks. For tissue collection, animals were sacrificed
by decapitation, their brains dissected, flash frozen at 230uCi n2 -
methylbutane, and stored at 280uC. For tissue punches of specific
regions, brains were embedded in OCT media and sectioned on a
Leica (CM3050) cryostat at 225uC as follows (according to
Paxinos & Franklin Mouse Brain Atlas, 2
nd ed.): 1) TMN: Two sets
of two 400 mm bilateral 1 mm diameter punches from Interaural
1.56 to 0.76; 2) LC: Two sets of two 300 mm bilateral 1 mm
diameter punches from Interaural 21.40 to 22.00; 3) Pons: Two
sets of one 300 mm 2 mm diameter punch from Interaural 21.40
to 22.00. Punches from the same brain region were pooled from
each of the animals within the same group, and stored at 280uC
until RNA isolation. All animal care and use procedures were in
strict accordance with University of Wisconsin IACUC and
National Institute of Health guidelines for the humane treatment
of laboratory animals.
Northern Blot Analysis
Northern blotting was performed essentially as described
previously [28]. Briefly, brains were dissected and total RNA was
isolated using TRIZOL (Invitrogen, Carlsbad, CA), according to the
manufacturer’s specifications,andstored at280uC.Prior to loading,
each sample was incubated with sample buffer (7.5%Formaldehyde,
43%Formamide, 12% 10XMOPS, 0.12%Ethidium Bromide) for
5m i na t5 6 uC, and then cooled on ice for 5 min. Northern Blots
consisted of 1 mg of total RNA per lane and were electrophoresed on
a 1.2% agarose gel. RNA was transferred overnight onto a sheet of
GeneScreen Plus nitrocellulose (NEN Life Science Products, Boston,
MA). DNA templatesgenerated byPCR were labeled with
32Pu s i n g
the Megaprime DNA labeling system (Amersham Biosciences,
England). Fabp7 forward primer, AGACCCGAGTTCCTCCA-
GTT, reverse primer, CCTCCACACCGAAGACAAAC. Fabp5
forward primer, CAATTCAGTGAGCGGTCAAA, reverse prim-
er, TAAGCTTGGATCTCCCTTTATTCTATAAAA. Probe was
mixed with hybrisol, and incubated overnight at 42uC. Blots were
washed three times in 26SSC (16SSC=150 mM NaCl, 15 mM
Na citrate, pH, 7.0), 1% SDS at room temperature, then two times
for 30 min in 26SSC, 1% SDS at 50uC, and finally one time for
30 min in 0.56SSC, 1% SDS at 60uC. Following washes, blots were
exposed to a phosphoscreen for 3 days and image analysis was
performed using the Storm 860 and ImageQuant 5.2 software
(Molecular Dynamics, Sunnyvale, CA). A 983-bp PCR product for
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was generated
as described previously [28].
Quantitative Reverse Transcriptase PCR
All quantitative reverse transcriptase PCR (qRT-PCR) was
performed at the University of Wisconsin-Madison Genome
Center. Complementary DNA was generated using Superscript
II Reverse Transcriptase (SSRII; Invitrogen, Carlsbad, California)
as follows: Five mg of total RNA was added to 100 pmole of T7
oligo(dT) primer (GGCCAGTGAATTGTAATACGACTCAC-
TATAGGGAGGCGG-d(T)24) and the reaction volume was
brought to 12 ml total volume with PCR grade water. The
reaction was incubated at 70uC for 10 minutes in a Mastercycler
ep thermocycler (Eppendorf, Hamburg-Eppendorf, Germany) and
placed on ice for 2 minutes. Four mlo f5 6SSRII buffer, 2 mlo f
0.1 M DTT, and 1 ml of 10 mM dNTPs were added and the
reaction was incubated in a thermocycler for 2 minutes at 42uC.
After incubation, 1 ml of SSRII reverse transcriptase was added
and the reaction was incubated at 42uC for 1 hour. cDNA was
then quantified using an ND-1000 Spectrophotometer (NanoDrop
Technologies, Wilmington, Delaware) and normalized to 20 ng/
ml with PCR grade water.
PCR Methods: Individual reactions contained 16 Probes
MasterMix (F. Hoffmann-La Roche Ltd, Basel, Switzerland),
0.05 U Uracil-N-Glycosylase, 16LCGreen Plus (Idaho Technolo-
gy, Salt Lake City, Utah), 200 nM of each primer and 20 ng of
cDNA. Fabp7 mRNA forward primer, CTCTGGGCGTGGGC-
TTT, reverse primer, TTCCTGACTGATAATCACAGTTG-
GTT, Fabp7 intron 1 forward primer, CGTACTGTTTTCTTCT-
TAACTCTGTATTTTG, reverse primer, GATTTCTGAAC-
TATTTTGGAAGTTGCTG. The total reaction volume of 5 ml
was overlaid with 10 m of Chillout Wax (Bio-Rad Laboratories,
Hercules, California). All reactions were run on a LightCycler 480
Real-Time PCR System (F. Hoffmann-La Roche Ltd). The cycling
parameters were; 50uC for 5 minutes, 95uC for 10 minutes and then
50 cycles of 95uC for 15 seconds and 60uC for 30 seconds.
Fluorescence data was collected at a wavelength setting of 450–
500 nm. Analysis was performed using both the LightCycler 480’s
proprietary software and qBASE v1.3.5 (Jan Hellemans, Center for
Medical Genetics, Ghent University, Belgium).
In Situ Hybridization
In situ hybridization was performed as previously described [71].
Briefly, post-fixed, cryostat sections (20 mm) were pretreated with
Proteinase K (0.2 mg/ml; Promega, Madison, WI) and hybridized
overnight at 55uC in 150 mlo f
35S-labeled antisense riboprobe
(10,000 cpms/ml). Following posthybridzation washes, sections
were exposed to a phosphoscreen for 6 days. Image analysis was
performed using the Storm 860 and ImageQuant 5.2 software
(Molecular Dynamics Sunnyvale, CA). For densitometric analysis
of in situ hybridization data, specific regions from a minimum of
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normalized to background as described previously [72].
Antisense (
35S- or digoxigenin (DIG) -labeled) riboprobe was
made from Fabp7, Nestin or Glial fibrillary acidic protein (GFAP)
PCR templates derived from T7-tagged reverse or forward
primers, respectively. Fabp7 forward primer: AGACCCGAGTT-
CCTCCAGTT, reverse primer, CCTCCACACCGAAGA-
CAAAC; Nestin forward primer, GGTCAAGACGCTGGAG-
GAG, reverse primer, GGAGACCTGGCTCACTTTTTC;
GFAP forward primer: AATGCTGGCTTCAAGGAGAC, re-
verse primer, AGGACAACTGAGCGGACACT. Templates used
for in vitro transcription were generated using standard PCR
conditions. T7 sequence tag extending the reverse primer was
GGCCAGTGAATTGTAATACGACTCACTATAGGGAGG-
CGG. In vitro transcription reactions were carried out as described
by Promega Biotech (Madison, WI) for
35S-labeled riboprobe and
by Hoffman-La Roche (Nutley, NJ) for DIG-labeled riboprobe.
For emulsion autoradiography, sections processed for in situ
hybridization were dipped in NTB3 liquid emulsion (Eastman
Kodak, Rochester, New York) under safelight conditions and
stored at 4uC for 6 weeks. Processing was as described by the
manufacturer. Following development, sections were lightly
stained in cresyl violet (0.1%), dehydrated in an ethanol series
and mounted. For double in situ hybridization analysis, sections
were hybridized to both riboprobes, washed as described above
and then processed for alkaline phosphatase as described by the
manufacturer (Hoffman-La Roche, Nutley, NJ). Sections were
then processed with autoradiographic emulsion for 6 weeks.
For analysis of diurnal time points using emulsion autoradiog-
raphy, all sections within a series were processed under identical
conditions in the same run (N=2–5 animals per group). The
subgranular zone (SGZ) of hippocampus was analyzed using
Image J software (NIH; http://rsb.info.nih.gov). Briefly, the
ventral SGZ in dorsal hippocampal sections extending from
Interaural 1.62 to 2.22 mm were boxed (minimum of four sections
per time point per animal), counts tabulated and background
subtracted, and averaged. Final values were calculated by
averaging across animals (N=2–5 per group). Prior to emulsion
autoradiography, changes in hippocampus were cross-validated
using phosphorimaging.
Western blotting
Samples prepared from whole brain were subjected to SDS-
polyacrylamide gel electrophoresis by separating 10 mg protein per
lane on a 10–20% gradient pre-cast gel (Biorad, Hercules, CA).
Protein was transferred to 0.2 mm Protran nitrocellulose mem-
branes (PerkinElmer, Boston, MA), blocked in 5% dried milk
powder in 50 mM Tris-HCl, pH 7.5, 15 mM NaCl, 0.5% Tween-
20 (TBST), washed briefly in TBST and incubated in primary
antibody in TBST overnight at 4uC. Fabp7 antibody (Chemicon,
Temecula, CA) was used at 1:1000 dilution in TBST, antibody to
b-actin (Imgenex, San Diego, CA) was used at 1:10,000 dilution
and anti-glyceraldehyde-3-phosphate dehydrogenase (Gapdh;
Imgenex, San Diego, CA), at 1:5,000 dilution. Blots were then
washed 3 times in TBST, incubated for 1 hour in anti-rabbit horse
radish peroxidase-conjugated secondary antibody (1:7500 in
TBST; KPL, Gaithersburg, MD), washed 3 times in TBST and
incubated in ECL plus Western blotting detection reagent for
5 minutes based on the manufacturers instructions (GE Health-
care, Buckinghamshire, UK). Visualization was performed by
chemoluminescence scanning (medium sensitivity, photomultiplier
voltage, 600 volts) on a Typhoon 9410 phosphorimager (GE
Healthcare, Buckinghamshire, UK). Densitometric analysis was
performed using ImageQuant version 5.2.
Immunohistochemistry
Sections were cut at 50 mm on a vibrotome and stored in 0.01 M
phosphate-buffered saline (PBS; pH 7.4) and 0.01% azide solutions
until processing. Sections were thoroughly washed in PBS, and
endogenase peroxidase activity was quenched by incubation for
10 minutes in PBS containing 10% methanol, 2.5% hydrogen
peroxide. Sections were again rinsed,then placed in blocking solution
containing 10% normal goat serum (NGS) and 0.2% Triton X-100
for 30 min. Sections were rinsed four times in PBS and then
incubated with the primary Fabp7 antibody (1:2000 dilusion) at 4uC
for 72–96 h. After three rinses in PBS, sections were incubated in
AlexaFlour goat anti-rabbit 2uantibody (1:400; Invitrogen, Carlsbad,
CA) for 2 h. Following rinsing and coverslipping, photographic
images were taken on a Leica DMI 6000 B inverted microscope.
Supporting Information
Figure S1 Fabp7 messenger (m-) and heteronuclear (hn-) RNA
underwent changes in abundance over a 24 hour period. RNA
from pons subjected to quantitative RT PCR (qPCR) revealed
diurnal changes in Fabp7 mRNA expression that mirrored results
from Northern blotting. qPCR for Fabp7 intron 1 (average of
TMN, pons, and LC) used as a measure of heteronuclear RNA
and therefore transcriptional activity, identified elevated levels of
intron 1 near the end of the dark period and after lights-on. Note
that increases in Fapb7 hnRNA immediately preceded the apex of
Fabp7 mRNA. RNA levels are normalized against Gapdh.
Found at: doi:10.1371/journal.pone.0001631.s001 (0.21 MB TIF)
Figure S2 Fabp7 mRNA did not cycle in early postnatal brain. A)
RNA collected from postnatal day (P) 6 whole brain analyzed with
qPCR identified significantly higher levels of Fabp7 compared with
adult whole brain (relative to Gapdh); ***p,0.001 (t-test) B) Analysis
by qPCR of Fabp7 mRNA levels across the day revealed statistically
significant diurnal changes in adult whole brain that mirrored
previous results, while there were no diurnal changes in P6 whole
brain (relative to Gapdh, normalized to mean levels within age
group); Two-way ANOVA, (p=0.004); A significant difference in
diurnal levels were observed between adult and P6: ZT2.5,
**p,0.01; ZT14.5, *p,0.05 (post-hoc Bonferroni). Each value
represents the average +/2 S.E.M. N=2–3 per timepoint. Animals
were maintained on a 10:14 hour light-dark schedule.
Found at: doi:10.1371/journal.pone.0001631.s002 (0.24 MB TIF)
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